Santhera Pharmaceuticals

About:

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

Website: http://santhera.com

Twitter/X: santhera

Top Investors: Dow, Idorsia, Novartis Venture Fund, 3i Group, Oxford Bioscience Partners

Description:

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.